INTRODUCTION
The Ahmed glaucoma tube shunt, introduced in 1993 [1] , is used in the management of elevated intraocular pressure (IOP) and glaucoma [2, 3] . The Ahmed design incorporates a flow restrictive device, thus reducing the incidence of postoperative hypotony [4] and making the Ahmed of particular utility in uveitic glaucoma [5] . After Ahmed implantation, the device progresses through predictable phases, including a hypertensive phase coinciding with encapsulation and bleb formation over the Ahmed plate. This phase is generally associated with an increase in IOP to greater than 21 mmHg [6] . Excessive inflammatory response after Ahmed implantation appears to be associated with higher failure rates and elevated IOP [7, 8] .
Studies have demonstrated the importance of permeability of the capsule overlying the Ahmed plate in determining the long-term control of IOP [9, 10] . Anti-inflammatory agents have been shown to be associated with thinner-walled capsules and lower IOP in certain patient populations [11, 12] . Indeed, recent studies using long-term topical steroid tapers, as well as aqueous suppressants after Ahmed implantation appear to show a reduction in the degree of IOP elevation during the ocular hypertensive phase, as well as an improvement in the long-term IOP control [13] . 
Statistical Analysis
The statistical analysis was performed using the Microsoft Excel and GraphPad Prism 6 software (La Jolla, California, USA). A Student t test was performed to determine whether there was significant difference in measured outcomes between the two groups at baseline and at 6 month post-Ahmed surgery. The duration of surgical success was compared between the two groups using Kaplan-Meier curves and the log-rank test. A multivariate regression analysis was performed to evaluate the relationship between surgical success and multiple variables. P values less than 0.05 were considered statistically significant.
RESULTS

Baseline Characteristics
Seventeen eyes of 13 participants were studied in the combined Ahmed and Retisert group. 
Intraocular Pressure
After Ahmed implantation, both the Ahmed only and combined Ahmed and Retisert groups had a significant reduction in mean IOP on postoperative day 1 (Fig. 1) . The initial reduction in IOP immediately after Ahmed implantation was followed by a gradual increase in the IOP at the 1 month time point in both the groups, consistent with the hypertensive phase of Ahmed implants (Fig. 1) . There was no statistically significant difference in IOP at any time point up to 6 months between the groups post-Ahmed implantation (Fig. 1) . The final mean IOP at 6 months was 15.3 ± 4.8 and 15.1 ± 4.9 mm Hg (p = 0.89) in the Ahmed only and combined groups, respectively.
Number of IOP-Lowering Medications
The number of IOP-lowering medications immediately after Ahmed implantation was significantly reduced in both the Ahmed only group and the combined Ahmed and Retisert group (Fig. 2 
Visual Acuity
Immediately after Ahmed implantation, a trend towards worsening VA was noted in both the Ahmed only and the combined Ahmed and Retisert groups (Fig. 3) . However, the VA in both the groups trended towards an improvement, and reached levels similar to baseline VA prior to Ahmed implantation (Fig. 3) . The VA at unchanged from baseline levels ( Table 1) .
Systemic Immunosuppression and Active Inflammation
Post-Ahmed implant systemic immunosuppression was required in a larger proportion of eyes in the Ahmed only group (52.9, 43.8, and 35.7% at 1, 3, and 6 months, respectively) relative to the combined Ahmed and Retisert group (11.8, 6.2, and 6.7% at 1, 3, and 6 months, respectively). This difference was statistically significant at 1 and 3 months, but not at 6 months (p B 0.01, 0.01, and 0.06, 
Surgical Success
Using the Kaplan-Meier survival analysis, there appeared to be a trend towards higher surgical success in the combined Ahmed and Retisert group relative to the Ahmed only group, however, we found no statistically significant difference in the duration of surgical success between the two groups (p = 0.32, Fig. 4 ). The cumulative probability of success at 6 months was 41.2% and 35.2% for the combined Ahmed and Retisert and the Ahmed alone groups, respectively. The principal reason for failure in both groups was sustained ocular hypertension, with the largest drop in surgical success being noted around the 1 month postoperative period (Fig. 4) . With multivariate regression analysis, 
